University of Hertfordshire Research Archive

        JavaScript is disabled for your browser. Some features of this site may not work without it.

        Browse

        All of UHRABy Issue DateAuthorsTitlesThis CollectionBy Issue DateAuthorsTitles

        Arkivum Files

        My Downloads
        View Item 
        • UHRA Home
        • University of Hertfordshire
        • Research publications
        • View Item
        • UHRA Home
        • University of Hertfordshire
        • Research publications
        • View Item

        Characterization of latent heat-releasing phase change materials for dermal therapies

        Author
        Wood, D.G.
        Brown, Marc
        Jones, S. A.
        Murnane, D.
        Attention
        2299/9419
        Abstract
        Phase change materials (PCMs) have been developed as heat storage solutions, particularly for the supply of “green” energy. One interesting use of PCMs is long-term energy storage, in which a phase transition is triggered externally. In addition, PCMs are a potential method of administering heat for therapeutic purposes (therapeutic hyperthermia). This exciting therapeutic intervention provides an adjunct to chemotherapy and the potential to improve drug absorption. The purpose of this study was to characterize and control the heat generation process from supercooled salt PCMs. Salts were selected on the basis of their lack of toxicity and previous use in medicine. The crystallization of sodium formate, acetate (SA), and thiosulfate (ST) was characterized and monitored for heat generation. Only SA and ST had the wide metastable limits and exothermic crystallization appropriate for safe dermal hyperthermia (32−50 °C). The crystallization rate, heating profile, and heat capacities (Cp) of the PCM and dry crystals at different supersaturation levels (high (H) and low (L)) were determined. A low degree of supersaturation produced lower maximum temperatures (e.g., SAHTmax = 55.7 ± 0.3 °C, SALTmax = 39.1 ± 0.3 °C), whereas low crystallization rates provide prolonged hyperthermia (e.g., STH DUR 1125 s). The heat release profiles can be optimized for therapeutic applications by controlling the following variables: (1) mass of salt which crystallizes (enthalpy released), (2) rate of crystallization, and (3) relative heat capacities of the supercooled solution and crystalline material. As an example, therapeutically relevant hyperthermia increased lidocaine flux across a model skin membrane from 7.18 ± 1.8 to 33.7 ± 2.6 μg cm−2. The current study has characterized the thermogenesis from pharmaceutically acceptable materials and provides for the development of PCMs as reliable, effective, and therapy-specific heat administration systems.
        Publication date
        2011-04-28
        Published in
        Journal of Physical Chemistry C
        Published version
        https://doi.org/10.1021/jp109518k
        Other links
        http://hdl.handle.net/2299/9419
        Metadata
        Show full item record
        Keep in touch

        © 2019 University of Hertfordshire

        I want to...

        • Apply for a course
        • Download a Prospectus
        • Find a job at the University
        • Make a complaint
        • Contact the Press Office

        Go to...

        • Accommodation booking
        • Your student record
        • Bayfordbury
        • KASPAR
        • UH Arts

        The small print

        • Terms of use
        • Privacy and cookies
        • Criminal Finances Act 2017
        • Modern Slavery Act 2015
        • Sitemap

        Find/Contact us

        • T: +44 (0)1707 284000
        • E: ask@herts.ac.uk
        • Where to find us
        • Parking
        • hr
        • qaa
        • stonewall
        • AMBA
        • ECU Race Charter
        • disability confident
        • AthenaSwan